1.Mermel, LA, Allon, M, Bouza, E, et al.Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49(1):1–45.
2.Safdar, N, Maki, DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006;43(4):474–484.
3.van de Wetering, MD, van Woensel, JB. Prophylactic antibiotics for preventing early central venous catheter gram positive infections in oncology patients. Cochrane Database Syst Rev 2007;(1):CD003295.
4.Sanders, J, Pithie, A, Ganly, P, et al.A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother 2008;62(4):809–815.
5.Yahav, D, Rozen-Zvi, B, Gafter-Gvili, A, Leibovici, L, Gafter, U, Paul, M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008;47(1):83–93.
7.Raad, I, Hanna, H, Jiang, Y, et al.Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007;51(5):1656–1660.
8.Fortun, J, Grill, F, Martin-Davila, P, et al.Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. 7 Antimicrob Chemother 2006;58:816–821.